The JCO publication describes a prospective analysis (prior to unblinding) performed in the intended target tumor population, patients with IDH mutant grade 3 (without CDKN2A/B homozygous deletion) ...

The Precision Fermentation Market is expanding rapidly as advancements in synthetic biology, growing consumer preference for sustainable and alternative proteins, and increasing investments in ...

The Precision Fermentation Market is expanding rapidly as advancements in synthetic biology, growing consumer preference for sustainable and alternative ...

Drug discovery is a high-risk, high-cost endeavor, with over 90% of candidates failing in clinical development. A significant proportion of these failures stem from unresolved biopharmaceutic ...

Drug discovery is a high-risk, high-cost endeavor, with over 90% of candidates failing in clinical development. A significant proportion of these ...

Leading Edge Health's GenuinePurity brand addresses authentication challenges and bioavailability concerns with certificate ...

Explore the devastating effects of turkey reovirus, industry challenges, and innovative research seeking breakthrough ...

Research reveals biotin competition in the nasal cavity affects Staphylococcus aureus growth, highlighting potential ...

Imagine having a blood type so rare that only two other people in the entire world could match it. That’s the reality for ...

Emerging TNBC therapies include TECENTRIQ (Hoffmann-La Roche), IPI-549 (Infinity Pharmaceuticals), Leronlimab (CytoDyn), MDNA11 (Medicenna Therapeutics), VIP236 (Vincerx Pharma), and CFI-400945 ...

Background Hypertension is a significant risk factor for cardiovascular disease, dementia and chronic kidney disease (CKD).

Amino acids that were abundant since the prebiotic era are enriched in protein binding sites of the most ancient coenzymes, supporting the plausibility of an early coenzyme–peptide world.